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A POLAROGRAPHIC STUDY OF SERUM ALTERATIONS FOLLOWING
ULTRAVIOLET IRRADIATION*
RYOHET OGURA, M.D., PH.D. AND JOHN M. KNOX, M.D.
The exact mechanism whereby ultraviolet
irradiation injures the skin is not known. When
a molecule absorbs a quantum of ultraviolet
energy it may disassociate, react with another
molecule upon collision, transfer the energy to
another molecule, or fluoresce. Ultraviolet wave
lengths between 2900 and 3200 A are responsible
for most of the adverse effects produced by
sunlight and proteins are known to absorb wave
lengths in this range (1).
One objective means of studying alterations
in protein is by use of a polarograph. Brdicka's
total protein reaction reveals a characteristic
double-wave pattern; therefore, alterations such
as occur with denaturation of protein can be
detected by performing the polarographic
procedure. Ultraviolet irradiation is also known
to change sulfhydryl and disulfide content of
serum proteins, so two relatively simple and
reasonably accurate methods are available for
determining ultraviolet-induced alterations of
protein. The purpose of this investigation was to
determine the effects of ultraviolet irradiation
upon serum and to discover whether or not these
changes could be prevented by the addition
chloroquine or ultraviolet-absorbing agents
prior to irradiation.
MATERIALS, METHODS AND RESULTS
Five millimeters of horse serum containing the
specified type and quantity of chemical agent
were spread over the surface of a small petri dish
(diameter 2.8 cm.), forming a layer approximately
1 cm. in thickness. The serum was then irradiated
with a hot quartz mercury vapor ultraviolet light
sourcet at a distance of 25 cm. The irradiated
material and unirradiated control serum contain-
ing the chemical were polarographed in an am-
monium-cobaltous solution immediately after
irradiation. Also, non-irradiated absolute con-
trol samples without a chemical additive were
similarly studied. The serum samples were ir-
radiated for 15 minutes in open air at room tem-
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perature. Prior to irradiation the serum tempera-
ture was 24° C., whereas following irradiation it
was elevated to 28° C. In a previous study the
loss of water from serum was found to be approxi-
mately 0.9% and not great enough to significantly
alter results (2).
Polarograp/tic Procedure (Brdicka's Total
Protein Reaction) (2, 3)
A sample of 0.1 g. of pepsin was dissolved in
100 ml. of 0.05 N HC1. and 5 ml. of the resulting
solution was heated on a water bath to 40° C.
Exactly 0.2 ml. of serum was added and heated
at the same temperature for 30 minutes. The
heated solution (0.2 ml.) was diluted with 10 ml.
of cobaltous solution (0.001 M CoCl2, 0.1N NH4C1,
0.1 N NH3) and polarographed from —1.0 volt
against the saturated calomel electrode. The
dependence of the height of the protein double-
wave was measured from the diffusion current
for the reduction of divalent cobalt to the highest
point of the double wave.
Amperometric Titration (4)
For comparison with the polarographic protein
wave height results, quantitative determinations
of serum sulfhydryl groups were performed by
employing an amperometric mercuric titration
technic using a rotating platinum electrode.
Thirty ml. of a titrating solution including the
0.5 ml. of serum to be analyzed were introduced
into a 120 ml. titration vessel. The titrating solu-
tion was 0.01 M of monosodium phosphate
(NaH2PO4), 0.08 M of disodium phosphate (Na2
HPO4), and 0.5 M of potassium chloride (KCI).
While passing a gentle stream of nitrogen through
the solution, protein sulfhydryl in serum is ti-
trated with mercuric chloride (10' M) at an ap-
plied potential of —0.2 volts against the saturated
calomel electrode.
In this study para-aminobenzoic acid, 3-
benzoyl -4 - hydroxy -6 -methoxybenzenesulfonic
acid and chloroquine were the chemicals selected
as additives (5—8). The chemical structural formu-
lae are shown in Fig. 1. Tables 1, 2, and 3 show the
concentration of drug that is necessary to prevent
the specified quantity of radiation from altering
serum protein. Under the conditions of this ex-
periment all three agents were capable of protect-
ing the serum in relatively low concentrations.
From the Tables it can be seen that both methods
detected changes almost simultaneously and were
in excellent agreement. The effective concentra-
tion for chloroquine was 64 mM, whereas
3 - benzoyl - 4 - hydroxy - 6 - methoxy - benzene-
7—chloro—4-(4—diethylaaino—1—methy—
butylainino) quinoline diphosphate
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FIG. 1
sulfonic acid was sufficient in 1.0 mM amount with
PABA assuming an intermediate position of pro-
viding protection at 16 mM. The data is presented
graphically in Fig. 2.
COMMENT
The finding that ultraviolet absorbers, such
as para-aminobenzoic acid and 3-benzoyl-4-
hydroxy-6-methoxy-benzenesulfonic acid are ca-
pable of protecting serum proteins from ultra-
violet-induced alterations could be expected;
however, one would have hesitated to predict
the results with chloroquine. Cahn, Levy, and
Shaffer (9) presented excellent data indicating
that the therapeutic effects of chioroquine were
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Chemical Structural Formulae TABLE 1
Chioroquime
Polarographic protein wave height
PABA
p—ansinobenzoic acid
NH COOH
BsA
3-benzoyl-4—hydroxy—6—inethoxy—
benzenesulfonic acid
SO3H
C1{LOROQUINE
ALTERATIONS FOLLOWING ULTRAVIOLET IRRADIATION
Protective Effect of Sunscreen Agents
On The Serum Protein
Effective Concentration
mliii mole
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not related to an ultraviolet absorbing action.
Figure 3 illustrates the absorption spectra for
all three agents employed and it can be seen
that chloroquine is not an efficient absorber in
the 2900 to 3200 A region. A wide variety of
theories have been advanced as to the mech-
anism of action of antimalarial drugs in lupus
erythematosus and polymorphic light sensi-
tivity reactions; however, no theory has been
adequately substantiated. The most interesting
theories are related to a possible effect on nucleo-
protein, (10) adenosintriphosphate, (11) or flavin
enzymes (12).
Apparently a significant change that occurs
in serum following ultraviolet irradiation is a
partial denaturation of protein for with de-
naturation there is a liberation of sulffiydryl or
disulfide groups and alterations in the catalytic
double-wave height. Chloroquine and ultraviolet
absorbers are capable of protecting serum proteins
from such changes.
SUMMARY
Two objective means of determining serum
protein changes were employed to see if chloro-
quinc or ultraviolet absorbers could prevent
protein from being altered by ultraviolet irradia-
tion. These agents were found to be capable of
protecting serum proteins from the ultraviolet-
induced changes that were detectable by either
analytical method.
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